The library / Topic

Research

Research is the largest topic and the one with the thinnest evidence. Most compounds here are sold online as laboratory products and have been studied in cells, rodents or a few small human reports, if at all. Each article separates those layers, names the species and the stage of every study, and explains why a dosage chart built on rat data is not a human dose.

The overview of what is known about research peptides is the best entry point. MOTS-c sorted by evidence level shows the method applied to one molecule, and the IGF-1 LR3 evidence review compares an unapproved analogue with the one approved IGF-1 label. For handling, see stability, storage and the cold chain.

Cover illustration for Research Peptides and the State of the Evidence
Research2 min read

Research Peptides and the State of the Evidence

Online forums are full of names and nicknames. What do we actually know about the compounds most often discussed, and why is the honest answer so often "not enough"?

Read
Cover illustration for Why Peptides Are Fragile and How Storage and the Cold Chain Help
Research2 min read

Why Peptides Are Fragile and How Storage and the Cold Chain Help

Peptides break down in surprising ways. Understanding why explains cold-chain logistics, expiry dates and why where a product has been matters as much as what is inside.

Read
Cover illustration for Machines That Invent Peptides and the New Era of AI Molecular Design
Research2 min read

Machines That Invent Peptides and the New Era of AI Molecular Design

Algorithms can now predict how chains fold and propose sequences no human has tried. What that means, and where hype ends and results begin.

Read
Cover illustration for ACE 031 Peptide and How It Works in Muscle Research
Research6 min read

ACE 031 Peptide and How It Works in Muscle Research

ACE-031 is a soluble activin receptor fused to an antibody fragment whose Duchenne trial was stopped in 2011 after nosebleeds and telangiectasias.

Read
Cover illustration for Epitalon Peptide Dosage Guide to How Published Schedules Were Built
Research6 min read

Epitalon Peptide Dosage Guide to How Published Schedules Were Built

Published epitalon doses span cell cultures, rodents and small Russian studies with different units and routes. None established a human dose, and the 2026 vote did not change that.

Read
Cover illustration for FOX04 Peptide Side Effects and Senolytic Research Overview
Research5 min read

FOX04 Peptide Side Effects and Senolytic Research Overview

FOXO4-DRI is a designed senolytic peptide studied in mice since 2017, with no human trials and therefore no established dose or side effect profile.

Read
Cover illustration for GHK Cu Peptide Injection Dosage and Protocol Explained
Research6 min read

GHK Cu Peptide Injection Dosage and Protocol Explained

No clinical trial has tested injected GHK-Cu in people, so cosmetic, cell and animal figures cannot be turned into a human dose, site or schedule.

Read
Cover illustration for KVP Peptide Explained and What KPV Research Shows
Research6 min read

KVP Peptide Explained and What KPV Research Shows

KPV is a tripeptide from alpha MSH that enters cells through the PepT1 transporter and reduces inflammation in animal colitis models, with no human trials published.

Read
Cover illustration for LL 37 Peptide Benefits Dosage and Research Evidence
Research5 min read

LL 37 Peptide Benefits Dosage and Research Evidence

LL-37 is the human cathelicidin, studied for antimicrobial and wound repair effects, with two topical leg ulcer trials and no approved systemic use.

Read